- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy
September 16, 2016
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
September 16, 2016
Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors
September 15, 2016
Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature
September 14, 2016
Acetazolamide serves as selective delivery vehicle for dipeptide-linked drugs to renal cell carcinoma
September 14, 2016
The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
September 10, 2016
Medical Expulsive Therapy is Underused for the Management of Renal Colic in the Emergency Setting
September 9, 2016
Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2α and inhibits tumor growth.
September 8, 2016
The interaction of sorafenib and regorafenib with membranes is modulated by their lipid composition
September 8, 2016
Outcomes of Laparoscopic Partial Nephrectomy in Patients Continuing Aspirin Therapy
September 8, 2016
An Empiric Evaluation of the Effect of Variation in Intensity of Follow-Up for Surgically Treated Renal Neoplasms on Cancer Specific Survival
September 7, 2016
Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinoma
September 6, 2016
Ultrasound-guided radiofrequency ablation for cT1a renal masses in poor surgical candidates: mid-term, single-center outcomes
September 6, 2016